tirzepatide for fatty liver Eli Lilly weight loss drug may treat disease Tirzepatide in metabolic dysfunction-associated steatotic

Nat Rev Endocrinol (2023) 19:53441

Lilly also took aim at the increasingly common sales of Mounjaro and Zepbound online, particularly on social media which the pharma says involves counterfeit, fake or compounded versions of these treatments

doi: 10.1111/j.1464-5491.1995.tb00553.x

This eliminates the cost barrier that discourages patients from optimizing their therapy, allowing your provider to focus on finding your true maximum effective dose rather than holding you back for financial reasons

Stopping treatment suddenly can lead to weight regain GLP-1 medicines help manage appetite, so stopping them quickly can bring back old eating patterns